Pfizer Inc.
PFE
$23.97
$0.100.42%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 06/29/2025 | 03/30/2025 | 12/31/2024 | 09/29/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -- | 623.66% | -90.82% | 10,790.24% | -98.68% |
| Total Depreciation and Amortization | -- | -9.73% | 2.35% | 1.16% | -0.29% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -120.48% | 523.61% | -2,592.86% | 96.67% |
| Change in Net Operating Assets | -- | -165.58% | 232.88% | 124.87% | -5.97% |
| Cash from Operations | -- | -65.26% | 0.10% | 476.98% | -263.39% |
| Capital Expenditure | -- | 38.50% | -40.86% | -2.20% | 9.52% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 643.63% | 49.79% | -126.85% | 114.98% |
| Cash from Investing | -- | 301.73% | 21.10% | -144.72% | 165.59% |
| Total Debt Issued | -- | -- | -66.13% | -52.71% | 216.48% |
| Total Debt Repaid | -- | 29.49% | 21.74% | 3.82% | -26.79% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -2.39% | 0.00% | 0.00% | -0.34% |
| Other Financing Activities | -- | -2,442.86% | -133.33% | 90.48% | 83.68% |
| Cash from Financing | -- | -2.21% | -10.31% | -88.53% | 50.13% |
| Foreign Exchange rate Adjustments | -- | 75.86% | -422.22% | 150.00% | 35.71% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -200.00% | -- |
| Net Change in Cash | -- | 931.11% | -255.17% | -91.55% | 116.05% |